Policy
Rare disease policy refers to the laws, regulations, and funding decisions that shape how people with rare conditions receive care. From newborn screening to insurance coverage, research investments to FDA approvals, these policies directly affect what treatments exist, who can access them, and how quickly.
With more than 30 million Americans living with a rare disease, and 95% of those conditions lacking an FDA-approved treatment, policy is often the difference between hope and hardship. Advocacy ensures our voices are heard in the rooms where these decisions are made.
Intro to Rare Disease Policy
Health policy is the framework of rules, systems, and priorities that govern health care in a society. It defines who is eligible for services, how care is delivered, what gets covered by insurance, how new treatments are approved, and how resources are distributed.
Who Policy Impacts
In rare disease policy, the impact of decisions are amplified by delayed diagnoses, limited treatments, and systemic gaps in care. Understanding who is impacted helps ensure we shape policy that is inclusive, patient-centered, and equitable.
Advocacy 101
Whether you’re new to advocacy or looking to take your passion further, here’s your starter guide to turning lived experience into lasting change. Learn about how a bill becomes a law, meeting with lawmakers, what to expect at hill days, and how to tell your story to drive change in rare disease policy.